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Background: The intercalation of perindopril erbumine into Zn/Al-NO3-layered double 
hydroxide resulted in the formation of a host-guest type of material. By virtue of the ion-
exchange properties of layered double hydroxide, perindopril erbumine was released in a 
sustained manner. Therefore, this intercalated material can be used as a controlled-release 
formulation.
Results: Perindopril was intercalated into the interlayers and formed a well ordered, layered 
organic-inorganic nanocomposite. The basal spacing of the products was expanded to 21.7 Å 
and 19.9 Å by the ion-exchange and coprecipitation methods, respectively, in a bilayer and a 
monolayer arrangement, respectively. The release of perindopril from the nanocomposite syn-
thesized by the coprecipitation method was slower than that of its counterpart synthesized by 
the ion-exchange method. The rate of release was governed by pseudo-second order kinetics. 
An in vitro antihypertensive assay showed that the intercalation process results in effectiveness 
similar to that of the antihypertensive properties of perindopril.
Conclusion: Intercalated perindopril showed better thermal stability than its free counterpart. 
The resulting material showed sustained-release properties and can therefore be used as a 
controlled-release formulation.
Keywords: perindopril erbumine, layered double hydroxides, ion-exchange, coprecipitation, 
sustained release, angiotensin-converting enzyme
Background
The administration of drugs designed to be given as a single dose rather than as 
multiple doses has recently been made possible using controlled-release formula-
tions. In this way, drug release can be accomplished over long periods of time, 
enabling an almost constant level of the drug to be maintained in the bloodstream. 
Moreover, sustained-release formulations increase the clinical efficacy of drugs.1 The 
introduction of drug nanocomposites as sustained-release vehicles has provided a 
breakthrough in novel drug delivery systems in the field of pharmaceutical technol-
ogy.2 Layered double hydroxides (LDH) are widely used for this purpose. Because of 
their unique properties, such as ease of preparation, low cost, good biocompatibility, 
low cytotoxicity, and full protection of the drugs loaded,3–5 LDHs have received 
considerable attention in the development of sustained-release or controlled-release 
drug delivery systems.
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Layered double hydroxides are also known as hydrotalcite-
like materials and anionic clays. They consist of brucite-like 
layers containing hydroxides of metal cations M2+ and M3+, 
and possess exchangeable anions, An- and a variable number 
of water molecules in the interlayer space. The chemical com-
position of LDH can be represented by the general formula:
[] ) MM (OH) (A mH O. 1x
2
x
3
2
xn
x/n2 -
++ +- ⋅ 5
Due to the anionic exchange properties of LDH, many 
pharmaceutically active compounds, especially those with 
negative charges or anions, have been intercalated into LDH 
brucite-like interlayers. As a result of ionic interactions, 
the intercalated actives are more stable, and usually show 
sustained release of the cargo molecules, which subsequently 
results in sustained drug levels. Such a property has been 
exploited for the controlled-release formulation of drugs such 
as the anticancer agent, 5-fluorouracil,6 the anti-inflammatory 
drug fenbufen,7 the antihypertensive drugs captopril, 
lisinopril, enalapril, and ramipril,8 and cardiovascular drugs, 
such as pravastatin and fluvastatin.9
Perindopril, (2S, 3aS, 7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-
ox-opentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahy-
droin-dole-2-carboxylic acid is an antihypertensive drug that 
acts by inhibiting angiotensin-converting enzyme (ACE).10 
Perindopril is a prodrug ester that is converted into the active 
diacid, perindoprilat, by hydrolysis after administration.11 It 
is administered orally in the form of tablets in a 1:1 ratio of 
perindopril salt with erbumine (tert-butylamine).
Complementary to previous research work,12,13 and 
due to the lack of previous studies on the intercalation 
of   perindopril erbumine (PE), we selected this agent as a 
model drug and intercalated it with Zn/Al-LDH using ion-
exchange and coprecipitation techniques. We focused our 
work on the structure, thermal properties, and slow-release 
properties of the as-synthesized drug-LDH nanocomposite, 
with the aim of using the resulting LDH-perindopril nano-
composite as a controlled-release formulation of the active 
drug, and study the effect of resulting nanocomposites on 
the angiotensin-converting enzyme.
Materials and methods
Materials
PE (C23H43N3O5, molecular weight 441.6) was purchased 
from CCM Duopharma (Berhad, Malaysia) at 99.79% 
purity and used as received. Other materials, including 
Zn (NO3)2 ⋅ 6H2O, Al (NO3)3 ⋅ 9H2O, NaOH, ACE, and 
hippuryl-histidyl-leucine, were purchased from Sigma 
(St Louis, MO) and used as received. Deionized water was 
used in all experiments.
Synthesis of Zn/Al-NO3 LDH
Zn/Al-NO3 was prepared according to the method described 
by Miyata14 with minor modifications. An aqueous solu-
tion of 2 mol/L NaOH was added dropwise to a   solution 
(250 mL) containing Zn2+ and Al3+ (molar ratio of Zn2+ 
to Al3+ is 4:1) with vigorous stirring until a pH of 7 was 
reached; the resulting solution was kept under a nitrogen 
gas   environment. The slurry was aged at 70°C for 18 hours, 
and then centrifuged and washed with deionized water and 
dried in an oven at 60°C.
Synthesis of PE-Zn/Al nanocomposite by  
ion-exchange
PE was intercalated into Zn/Al-NO3 using the ion-exchange 
method. An aqueous solution containing 3.54 g (0.008 mol) 
of PE in 100 mL of decarbonated water was added to 50 mL 
of an aqueous suspension containing 0.2 g of Zn/Al-NO3. 
The mixture was magnetically stirred for 2 hours at room 
temperature. The resulting material was filtered, washed 
with water, and finally dried in an oven at 60°C. The product 
was denoted as PZAE (perindopril intercalated into Zn/Al 
by ion-exchange).
Synthesis of PE-Zn/Al nanocomposite  
by coprecipitation
The PE-intercalated Zn/Al-NO3 was prepared using the copre-
cipitation method. An aqueous solution containing 2 mol/L 
NaOH and PE (4.43 g, 0.01 mol) was added dropwise into 
a solution (250 mL) containing Zn2+ and Al3+ nitrate (molar 
ratio of Zn2+ to Al3+ was 4:1) under a nitrogen atmosphere with 
vigorous stirring until a pH of 7 was reached. The resulting 
slurry was kept at 70°C for 18 hours. The aged slurry was 
then filtered, washed with water, and finally dried in an oven 
at 60°C. The product was denoted as PZAC (perindopril 
intercalated into Zn/Al by coprecipitation method).
Controlled-release study
Drug release profiles were determined at room temperature 
using phosphate-buffered saline at a concentration of 
0.01 mol/L and pH 4.8 and 7.4. About 85 mg of each 
nanocomposite was added to 500 mL of the media. The 
cumulative amount of PE released into the solution was 
measured at preset time intervals at λmax = 215 nm using a 
Perkin Elmer ultraviolet-visible spectrophotometer (model 
Lambda 35; PerkinElmer, Waltham, MA).
To compare the release rate of perindopril from LDH 
with that from the physical mixture of PE and Zn/Al-LDH, 
0.62 mg of a physical mixture of PE (0.2 mg) and the pristine 
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LDH (0.42 mg) was used. Release of the active perindopril 
was determined as described above.
MTT cytotoxicity and in vitro antihypertensive assay
Normal Chang liver cells was seeded at a density of 1 × 104 
cells/well into 96-well plates and kept at 5% CO2 and 37°C 
for 24 hours. The cell was then treated with PE, PZAE, 
and PZAC at concentrations of 1.25, 0.625, 0.313, and 
0.156 µg/mL. After 24 hours of incubation, cell viability 
was determined using a colorimetric assay based on the 
uptake of MTT by viable cells. The MTT-containing medium 
was removed gently and replaced with dimethylsulfoxide 
(200 µL/well) to mix the formazan crystals until dissolved. 
Absorbance at 570 nm and 630 nm (background) was 
  measured with a microtiter plate reader. All experiments 
were carried out in triplicate. The IC50 was generated from 
the dose-response curves for the cell line.
The in vitro antihypertensive activity of free perindopril 
and intercalated perindopril in LDH, (PZAE and PZAC) 
was assayed by measuring their ACE inhibition activity 
using the method reported by Cushman and Cheung.15 
In vitro ACE inhibition activity was quantified by 
converting hippuryl-histidyl-leucine to hippuric acid 
through ACE in the presence of the inhibitor; absorbance 
was measured at 228 nm. Any reduction in absorbance 
is proportional to the inhibition exerted by the assayed 
inhibitor. Perindopril, PZAE, and PZAC (0.5 µg/mL) 
were preincubated with ACE for 20 minutes in a 25 µL 
volume in buffer (pH 8.3), then mixed with 10 µL of 
3.5 mM hippuryl-histidyl-leucine. The assay mixture 
was incubated at 37°C for 30, 60, and 90 minutes. The 
reaction was stopped by adding 50 µL of 3 mol/L HCl. 
The hippuric acid formed by ACE was extracted with 
1 mL of ethyl acetate. The solvent was removed by heat 
evaporation and re-dissolved in deionized water. The 
amount of hippuric acid was measured using a fluorescent 
plate reactor at 228 nm.
Characterization
Powder x-ray diffraction patterns were recorded in the range 
of 2°C–70°C on a Shimadzu diffractometer, XRD-6000, using 
CuKα radiation (λ = 1.5418 Å) at 30 kV and 30 mA, with a 
dwell time of 0.5 degrees per minute. Fourier transform infra-
red (FTIR) spectra of the materials were recorded over the 
range of 400–4000 cm-1 on a Thermo Nicolet Nexus FTIR 
(model Smart Orbit) with 4 cm-1 resolution, using the KBr 
disc method with a 1% sample in 200 mg of spectroscopic 
grade potassium bromide, and making the pellets by pressing 
at 10 tonnes. The chemical composition of the samples was 
analyzed for zinc and aluminum ions by inductively coupled 
plasma atomic emission spectrometry using a Perkin-Elmer 
spectrophotometer (model Optima 2000DV) under standard 
conditions. For carbon, hydrogen, nitrogen, and sulfur (CHNS) 
analyses, a CHNS-932 LECO instrument was used. Thermo-
gravimetric and differential thermogravimetric analyses were 
carried out using a Mettler Toledo instrument with a heating 
rate of 10°C/minute, in the range of 20°C –1000°C under a 
nitrogen atmosphere (N2 flow rate 50 mL/minute). Surface 
characterization of the material was carried out using the 
nitrogen gas adsorption-desorption technique at 77 K and a 
Micromeritics ASAP 2000 instrument. A field emission scan-
ning electron microscope (Nova Nanosem 230 model) was 
used to determine the surface morphology of the samples. 
Ultraviolet-visible spectra were measured to determine the 
optical properties, and a controlled release study was per-
formed using a Perkin Elmer ultraviolet-visible spectropho-
tometer (Lambda 35).
Results and discussion
Powder X-ray diffraction
The X-ray diffraction patterns of perindopril intercalated into 
Zn/Al-LDH for the formation of nanocomposites obtained 
by both the ion-exchange and coprecipitation routes are 
depicted in Figure 1B and C, respectively. Figure 1A repre-
sents the x-ray diffraction pattern of Zn/Al-LDH. As shown 
in Figure 1A, the 003, 006, and 009 reflections were found 
for 2θ at about 9.79, 19.72, and 29.74 degrees, respectively. 
In addition, the two 110 and 113 reflections were found at 
60.3 and 61.2 degrees, respectively. The basal spacing value 
(d003, obtained by averaging the higher order peaks) of the 
pristine Zn/Al-NO3 was 9.01 Å, which is consistent with 
the data in the literature.16 The characteristic reflections of 
perindopril shown in Figure 1D were absent from the X-ray 
diffraction pattern of the product of reaction of PE with   
Zn/Al-NO3 LDH, suggesting that perindopril was intercalated 
into the interlayer galleries of the LDH rather than adsorbed 
onto the surface. This was confirmed by the shifting of the 003, 
006, and 009 diffraction peaks to low 2θ angles at 4.00, 8.31, 
and 12.5 degrees, respectively, when using the ion-exchange 
method (Figure 1B), and 4.29, 8.87, and 13.26 degrees, respec-
tively, when using the coprecipitation method (Figure 1C).
The lattice parameters of the Zn/Al-LDH, PZAE, and 
PZAC samples were calculated from the positions of the 
maxima due to reflection by planes, ie, 003 for parameter c, 
where [c = 1/3(3d003 + 6d006 + 9d009), and 110 for parameter 
a, where (a = 2d110)], as shown in Table 1. The reflection line 
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of diffraction peak 110 (1.53 Å) for the Zn/Al-LDH sample 
did not shift after the intercalation process, which indicates 
that intercalation of perindopril did not change the structure 
of the layer, but only changed the interlayer spacing.17
Molecular structure and spatial 
orientation of intercalated perindopril
The PE consisted of perindopril (free acid, Figure 2C) 
combined with erbumine (tert-butylamine). This   combination 
incorporates hydrogen bonds (Figure 2A) or involves the 
transfer of protons from the carboxylic group of perindopril to 
tert-butylamine (Figure 2B). During the intercalation process, 
the free acid of PE (Figure 2C), which is negatively charged 
on the carboxylic acid group, is preferentially intercalated into 
the inorganic interlayers of LDH. Therefore, we presumed that 
the perindopril anion of PE was intercalated into the inorganic 
interlayers. We subsequently estimated the dimensions of the 
perindopril anion and its spatial orientation.
The X-ray diffraction pattern shows that the d-spacing 
(d003) of the nanocomposites increased to 21.7 (obtained 
by averaging the higher three order peaks) and 19.9 Å 
(obtained by averaging the higher five order peaks) for 
PZAE and PZAC, respectively. Because the thickness of the 
LDH layer is constant at 4.8 Å,18 the gallery height of LDH 
after intercalation can thus be calculated by the d-spacing 
minus the thickness of the LDH layer; these values were 
16.9 Å (21.7–4.80 Å) and 15.1 Å (19.9–4.80 Å) for PZAE 
and PZAC, respectively. The long and short axes (x-axes 
and y-axes, respectively) and molecular thickness (z-axis) 
of perindopril were calculated using Chemoffice software 
(Cambridge, MA), giving values of 13 Å, 8.4 Å, and 12.6 Å, 
respectively. The gallery height of PZAE was 16.9 Å, which is 
much larger than the value of the long axis (13 Å), and slightly 
similar to double the short axis (16.8 Å). This suggests that 
the perindopril anions in PZAE were accommodated as an 
alternate bilayer, as illustrated in Figure 2D. A comparison 
of the long axis of perindopril (13 Å) with a gallery height 
of PZAC (15.1 Å) suggests that, in PZAC, perindopril anions 
were accommodated as a vertical monolayer (along the axis 
of perindopril) with the presence of water between the per-
indopril anions and this layer (Figure 2E).19
Infrared spectroscopy
The FTIR spectrum of Zn/Al-NO3 LDH is shown in 
Figure 3B. The absorption peak at 1384 cm-1 is due to nitrate 
groups. The broad absorption peak at 3452 cm-1 can be 
attributed to stretching of the O-H group, which is contained 
within the layer. The absorption peak at 1628 cm-1 is due to 
the bending of H2O,20 while the absorption at 428 cm-1 is due 
to Zn-Al-OH stretching.21
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Figure 1 Powder X-ray diffraction patterns for pristine Zn/Al-NO3 (A), the nano-
composite prepared using the ion-exchange method, PZAE (B), the coprecipitation 
method, PZAC (C), and perindopril erbumine (D). 
Abbreviations: Zn, zinc; Al, aluminum; LDH, layered double hydroxide; PZAE, 
perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated 
into Zn/Al by coprecipitation method.
Table 1 Lattice parameters and surface properties of samples
Samples d003 
(Å)
d110 
(Å)
a 
(Å)
c 
(Å)
BET surface area 
(m2/g)
BJH pore volume  
(cm3/g)
BJH pore diameter 
(Å)
ZnAl-NO3 9.01 1.53 3.07 27.02 1 0.008 243
PZAE 21.7 1.53 3.07 65.6 2 0.009 135
PZAC 19.9 1.54 3.07 59.8 7 0.025 157
Abbreviations: Zn, zinc; Al, aluminum; NO3, nitrate; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/AI-LDH by 
coprecipitation method; BJH, Barret-Joyner-Halenda; BET, Brunauer-Emmett-Teller.
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The FTIR spectra of PE (Figure 3A and Table 2) show 
many intense, sharp absorption peaks that are due to the 
  different functional groups present in the molecules, ie, 
primary amine, secondary amine, ester, carboxylic acid 
and methyl groups. Tert-butylamine shows three absorption 
peaks at 2871 cm-1, which can be attributed to the asym-
metric stretching of CH3,22 while the peak at 1247 cm-1 is 
due to C3C-N stretching22 and 1022 cm-1 indicates C-N 
stretching.23 The band at 2851 cm-1 can be attributed to 
CH in CH3-CH-NH and the band at 2929 cm-1 is due to 
CH in NH-CH-propyl. The secondary amine functional 
group shows a peak at 1154 cm-1 which is related to the 
symmetric stretching of C-N-C.23 The bands recorded at 
1745, 1209, and 1064 cm-1 are due to C=O, C-C-O, and 
O-C-C stretching, respectively, in the ester group.23 The 
band at 1731 cm-1 is due to the ν(C=O) stretching mode of 
the carboxylic group, which indicates that PE can exist in a 
neutral form24 (Figure 2A). The band at 1291 cm-1 is due to 
C-O stretching in the   carboxylic acid group.25
The FTIR spectra of the PZAE and PZAC are shown in 
Figure 4C and D, respectively, and the spectral assignments 
are shown in Table 2. The nanocomposite spectrum shows 
the characteristic bands of pure perindopril, which indicate 
that the perindopril anions are intercalated into the interlayer 
galleries of LDH. Table 2 shows that some of the bands are 
slightly shifted in position due to the interaction between 
the perindopril anion and the interlayers as a result of the 
intercalation process. The bands recorded at 1732 cm-1 
and 1729 cm-1 for the PZAE and PZAC nanocomposites, 
respectively, are due to the presence of perindopril in a neutral 
form adsorbed on the layer or due to an ester group.26,27 The 
appearance of new broad peaks at 1613 cm-1 for PZAE and 
1601 cm-1 for PZAC can be assigned to asymmetry stretching 
vibration of the COO- group. The shift in COO- asymmetry 
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Figure 2 Structure of perindopril erbumine (A–C) and molecular structural models of perindopril intercalated between the interlayers of LDH (D and E). 
Abbreviation: LDH, layered double hydroxide.
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for the PZAC nanocomposite to a lower wave number 
compared with PZAE presumably occurred due to the pres-
ence of water molecules between the layers, which bind the 
perindopril molecules and the inorganic interlayer.28 The 
band at 1384 cm-1 is due to the nitrate anion, which may 
not be completely removed from the interlayers during 
the intercalation process, and to the symmetric stretching 
  vibration of the COO- functional group.29
The bands below 600 cm-1 are due to metal-oxygen bonds; 
ν(M-O-M) stretching modes in the layers indicate that the 
structure of the layers is well maintained.30,31
Elemental analysis
Elemental analysis was conducted to determine the organic 
and inorganic composition of PZAE, PZAC, and Zn/Al-NO3 
LDH. As expected, the PZAE and PZAC nanocomposites 
contained both organic and inorganic constituents. This 
indicates that intercalation occurred in which perindopril was 
intercalated into the LDH inorganic interlayers.
Table 3 shows that the Zn2+/Al3+ molar ratio in Zn/Al-NO3 
LDH, PZAE, and PZAC is 3.5, 3.45, and 2.6, respectively. 
As a result of the elemental chemical analysis and thermo-
gravimetric studies, the empirical formula for LDH was 
determined to be  Zn Al OH) NO HO 0.78 0.22 23 2 (( ). . []
-
02 2 03 1 ⋅
. According to the FTIR spectra of PZAC and PZAE, 
the strong bands at 1384 cm-1 and 1385 cm-1 are due to 
the presence of trace amounts of a nitrate group in the 
interlamellar spacing of LDH. Based on the results of 
elemental chemical analysis and thermogravimetric studies, 
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Figure 3 Fourier transform infrared patterns of (A) perindopril erbumine, (B) Zn/
Al-NO3, (C) PZAE, and (D) PZAC. 
Abbreviations: Zn, zinc; Al, aluminum; LDH, layered double hydroxide; PZAE, 
perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated 
into Zn/Al by coprecipitation method.
Table 2 Assignment of FTIr absorption bands from PE, PZAE, 
and PZAC nanocomposites
PZAE  
(cm-1)
PZAC  
(cm-1)
PE  
(cm-1)
Stretching O-H 3453 3451 –
CH in NH-CH-propyl 2931 2933 2929
C=O in COOH – – 1731
Asymmetry COO- 1613 1601 –
Scissoring CH2 1468 1469 1466
Asymmetry bending CH3 1445 1446 1448
NO3 and symmetry COO- 1385 1384 –
C-C-O for ester 1202 1202 1209
C-N-C for secondary amine 1152 1132 1154
O-C-C ester 1069 1070 1064
Abbreviations: FTIr, Fourier transform infrared; PE, perindopril erbumine; PZAE, 
perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated 
into Zn/Al by coprecipitation method.
Table 3 Chemical compositions of Zn/Al-NO3 LDH, PZAE, and PZAC nanocomposites
Samples Zn%a Al%a C%b N%b C/N Drug%b Zn2+/Al3+ X
ZnAl-NO3 38.3 4.5 – 2.5 – – 3.5 0.22
PZAE 30.6 3.6 23.0 3.0 7.67 37.2 3.48 0.22
PZAC 25.2 3.9 20.7 3.3 6.3 33.4 2.6 0.28
Notes: aCalculated upon Industrial Control Products data; bcalculated upon carbon, hydrogen, nitrogen, and sulfur (CHNS) analysis data. 
Abbreviations: Zn, zinc; Al, aluminum; C, carbon; N, nitrogen; NO3, nitrate; PE, perindopril erbumine; PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, 
perindopril intercalated into Zn/Al by coprecipitation method.
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the empirical formula for PZAC was proposed to be 
Zn Al OH PE NO HO . 0.72 0.28 32 ()    () ()
--
2 0 177 0 103 09 1
.. . ⋅  The empiri-
cal formula for the PZAE nanocomposite can be given as 
Zn Al OH) PE )N OH O. 0.78 0.22 2 0.19 32 (( () . . []
-- ⋅ 00 3 04
Thermal analysis
The thermal behavior of the compounds before and after 
intercalation of perindopril into LDH was examined using 
thermogravimetric and differential thermogravimetric 
analyses. The thermal analysis of Zn/Al-LDH, PZAE, PZAC, 
and pure PE are shown in Figure 4. For PE (Figure 4A), two 
main thermal events were clearly observed. The first event, 
which occurred in the region of 90°C–192°C, was attributed 
to the melting of perindopril, corresponding to a sharp 
peak in the differential thermogravimetric curve at 157°C 
with 24.1% weight loss. This was followed by the second 
stage at 192°C–312°C, due to the decomposition and subtle 
combustion of perindopril,32 corresponding to the strong peak 
at 276°C and 81.2% weight loss. Figure 4B shows that the 
thermal decomposition of Zn/Al-LDH progressed through 
four major stages of weight loss; these occurred at temperature 
maxima of 100°C, 226°C, 302°C, and 787°C, with weight 
losses of 5.2%, 15.1%, 10.8%, and 1.2%, respectively. The 
first stage of weight loss in the range 32°C–152°C is due to 
the removal of water physisorbed on the external surface of 
LDH as well as structured water. The second and third stages 
of weight loss can be attributed to dehydroxylation of the 
metal hydroxide layers and decomposition of nitrate ions, 
and were completed at 484°C. The final stage of weight loss 
is related to the formation of spinel.33
Following the intercalation process, the thermal decom-
position characteristics of the resulting product were 
significantly different from those of the precursors. The 
thermogravimetric analysis curves for PZAE and PZAC 
showed four stages of weight loss. For PZAE (Figure 4C), 
the first weight loss of 4.2% was attributed to the elimination 
of surface water or physically adsorbed water and interlayer 
water at 63°C.34 The second and third weight losses were 
attributed to dehydroxylation of the layers and combustion 
of the perindopril at 199°C and 346°C, respectively. The 
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second and third stages usually overlapped.35 The fourth 
step with 7% weight loss at 781°C was due to the formation 
of ZnAl2O4.
The thermal decomposition characteristics of PZAC 
were similar to those of PZAE. Three weight losses at 73°C, 
186°C, and 299°C were associated with the removal of 
surface-adsorbed water, interlayer water, and dehydroxyla-
tion of the layer, as well as decomposition of perindopril, 
accompanied by 6.15%, 8.69%, and 31.8% weight loss, 
respectively (Figure 4D). Decomposition of perindopril in 
the PZAE and PZAC nanocomposites occurred at 346°C 
and 299°C, respectively, which is higher than that for free 
perindopril (276°C). This suggests that the thermal stability 
of perindopril in nanocomposites was clearly enhanced due 
to the intercalation process, which involves electrostatic 
attraction between the negatively charged functional group 
of perindopril and the positively charged brucite-like layers 
of LDH.
Surface properties
Figure 5A shows the nitrogen adsorption-desorption 
isotherms for Zn/Al-NO3, PZAE, and PZAC. All adsorption 
isotherms were Type IV according to the International Union 
of Pure and Applied Chemistry classification, indicating a 
mesoporous-type material.36 Adsorption increased slowly at 
low relative pressure in the range of 0.0–0.8, followed by rapid 
adsorption at relative pressures 0.8, reaching an optimum 
at more than 7.1, 6.9, and 18.9 cm3/g at standard temperature 
and pressure for Zn/Al-NO3, PZAE, and PZAC, respectively. 
The desorption branch of the hysteresis loop in PZAE and 
PZAC was wider than that of Zn/Al-NO3, indicating a dif-
ference in pore texture. This was due to modification of the 
pores as a result of the expansion of basal spacing due to the 
formation of the new nanocomposites.21
Table  1  shows  the  Brunauer-Emmett-Teller 
(BET)-specific surface area of Zn/Al-NO3 LDH and the 
nanocomposites, PZAE and PZAC. As shown in Table 1, 
the BET-specific surface area of the resulting nanocompos-
ites was higher than that of LDH. The BET surface area 
increased from 1 m2/g for Zn/Al-NO3 to 2 m2/g for PZAE 
and 7 m2/g for PZAC.
Figure 5B shows the Barret-Joyner-Halenda (BJH) des-
orption pore size distribution for Zn/Al-NO3, PZAE, and 
PZAC. As shown, a single-peaked pore size distribution was 
observed for Zn/Al-NO3, centered around 178 Å. On the 
other hand, PZAE and PZAC showed single peaks at 185 Å 
and 109 Å, respectively. The average pore volume and pore 
diameter shown by BJH desorption are given in Table 1. 
The BJH average pore diameters for Zn/Al-NO3, PZAE and 
PZAC were 243 Å, 135 Å, and 157 Å, respectively; the BJH 
pore volumes for the same samples were 0.008, 0.009, and 
0.025 cm3/g, respectively.
The surface morphology of Zn/Al-NO3 LDH, PZAE, 
and PZAC is illustrated in Figure 6. All samples showed 
typical non-uniform irregular agglomerates of compact and 
non-porous plate-like structures, similar to the   morphology 
of nanocomposites discussed in the literature.37 PZAC had 
a smoother surface morphology than Zn/Al-NO3 LDH 
and PZAE.
Sustained-release study
The cumulative release profiles of perindopril from PZAE 
and PZAC, and its physical mixture, PE, with Zn/Al-
LDH in solution at pH 7.4 and 4.8, are shown in Figure 7. 
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Figure 6 Field emission scanning electron micrographs of ZnAl-NO3 (A), PZAE (B), and PZAC (C) at 25,000×. 
Abbreviations: Zn, zinc; Al, aluminum; NO3, nitrate; PZAE, perindopril intercalated into ZnAl by ion-exchange; PZAC, perindopril intercalated into ZnAl by coprecipitation 
method.
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The physical mixture showed no sustained-release effects 
in both   solutions at pH 7.4 and 4.8, with the total PE 
content released immediately. At pH 7.4 and 4.8, the 
release rate within the first 12 minutes reached 87% and 
97%, respectively. However, the perindopril-intercalated 
LDH nanocomposite gradually released perindopril anions 
over time, both at pH 7.4 and 4.8. At pH 4.8 (Figure 7I 
[B and D]), the first   aliquot contained a large number of 
  perindopril anions due to the “burst effect”,38 together with 
the release of perindopril anions adsorbed onto the outer 
surface of LDH. Subsequently (in acid media at pH 4.8), the 
LDH particles were destroyed and the intercalated perindo-
pril drug anions were released. The destruction of the layers 
increased the acidity (pH) of the solution and increased the 
rate of perindopril release in this medium. Therefore, release 
was faster at pH 4.8 than at pH 7.4. When the drug–LDH 
dissolution process reached equilibrium, 87% was released 
in 1100 minutes and 1020 minutes for PZAE and PZAC, 
respectively (Figure 7II [B and D]).
At pH 7.4 (Figure 7I [A and C]), the release of perindopril 
was rapid within the first 200 and 300 minutes, which can be 
attributed to the release of perindopril anions adsorbed on 
the outer surface of LDH as well as intercalated perindopril. 
Subsequently, however, the release of perindopril became 
much slower and sustained compared with the solution at pH 
4.8, with a total release equilibrium of 83% in 1263 minutes 
for PZAC and 70% in 1000 minutes for PZAE (Figure 7II 
[A and C]). This sustained-release process may be attributed 
to the ion-exchange process between the perindopril anions 
and the anions in the buffer solution.39,40 The release profile 
of perindopril from PZAE and PZAC shown in Figure 8 
is similar to that of other drugs from the host.6,8,41–43 
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Additionally, at pH 7.4, the duration of release of perindopril, 
which was arranged as a monolayer in the PZAC sample, 
was much longer than that of PZAE, which was arranged 
in a bilayer fashion (Figure 2D and E). It is possible that 
the perindopril anions that were arranged in a monolayer 
fashion in the interlayer showed weaker repulsive forces 
and a stronger affinity for the LDH interlayers. Thus, these 
structures may have been more difficult to destroy compared 
with the anions arranged in bilayers.
To gain more insight into the mechanism of release of 
perindopril from the nanocomposites, we used three types 
of kinetic models to fit the release data:
a.  The pseudo-first order model,41 which expresses release of 
perindopril from LDH; here the dissolution rate depends 
on the amount of perindopril in the nanocomposite and 
can be expressed as:
  ln (qe - qt) = ln qe – k1t  (1)
b.  The pseudo-second order kinetic equation,41 which is 
represented in the form:
  t/qt = 1/h + t/qe  (2)
where qe and qt are the equilibrium release amount and the 
release amount at any time (t), respectively, and h = k2qe
2.
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c. The parabolic diffusion model,44  which  can  be 
expressed as:
  (1 - Mt/Mo)/t = kdt-0.5 + a  (3)
where a is constant and kd is the overall diffusion constant 
for release. Mo and Mt are the amount of perindopril between 
the layers at release time 0 and t, respectively.
The data on perindopril release from the nanocomposites 
into the solutions were fitted into the above mentioned 
equations. The corresponding linear coefficient (R2) was 
evaluated, is summarized in Table 4, and is plotted in Figure 8. 
As shown, the pseudo-second order model was the most 
satisfactory for describing the release kinetics of perindopril 
from the nanocomposites, similar to previous studies reported 
in the literature.41 Figure 8 shows the plots of t/qt against t 
for the release of perindopril at pH 4.8 and 7.4. As shown, 
straight lines were obtained. For the release of perindopril 
at pH 4.8, the correlation coefficient values were 0.9999 
and 0.9903 for PZAE and PZAC, respectively, whereas the 
correlation coefficients at pH 7.4 were 0.9989 and 0.9983 
for PZAE and PZAC, respectively.
Table 4 shows the pseudo-second order rate constant for 
the release of perindopril from PZAE and PZAC. At pH 4.8, 
this was 5.7 × 10-4 and 1.3 × 10-4 mg/minute, respectively. 
At 7.4, the values were 7.4 × 10-4 and 3.8 × 10-4 mg/minute, 
respectively.
MTT cytotoxicity and in vitro 
antihypertensive activity
Figure 9 show the effect of PE, PZAE, and PZAC on viabil-
ity, using Chang cells at various concentrations of 0.156, 
0.313, 0.625, and 1.25 µg/mL and with 24-hour incubation 
times. As shown in Figure 9, PE did not have a cytotoxic 
effect on the viability of these cells. Interestingly, the PZAE 
and PZAC also had no toxic effect on the Chang cells at a 
concentration up to 1.25 µg/mL. These results are consistent 
Table 4 Correlation coefficient (R2), rate constants (k), and half-time (t1/2) obtained by fitting the perindopril release data from PZAE 
and PZAC nanocomposites into solutions at pH 4.8 and 7.4
Samples pH Saturation  
release  
(%)
R2 Pseudo-second order
Pseudo-first 
order
Pseudo-second 
order
Parabolic  
diffusion model
Rate constant, K 
(mg/min) × 10-4
t1/2 
(minutes)
PZAE 7.4 70 0.7026 0.9989 0.3846 7.4 18.9
PZAE 4.8 87 0.8417 0.9999 0.4530 5.7 19.3
PZAC 7.4 83 0.6035 0.9983 0.5120 3.8 31.6
PZAC 4.8 87 0.7842 0.9903 0.6956 1.3 77
Abbreviations: PZAE, perindopril intercalated into Zn/Al by ion-exchange; PZAC, perindopril intercalated into Zn/Al by coprecipitation method.
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with those of a study reported by Posati et al who showed 
that cytotoxicity is apparently selective for human cervical 
adenocarcinoma epithelial (HeLa) cells, because there is no 
significant cytotoxicity towards non-malignant Madin-Darby 
canine kidney cells.45
Several other investigations have demonstrated the 
antihypertensive potential of PE.46–48 Figure 10 and 
Table 5 show the first report of free Zn/Al layered double 
hydroxide and PE intercalated into Zn/Al, with ACE 
inhibition activity. The ACE inhibition activity of perindopril 
in PZAE and PZAC nanocomposites was determined in vitro 
by monitoring the transformation from a substrate hippuryl-
histidyl-leucine to the product hippuric acid. Of the two 
formulations, the PZAE showed the most potent ACE 
inhibition activity. That may be attributable to the high 
level of PE release from the PZAE nanocomposite when 
compared with PZAC. However, the ACE inhibition activity 
of both formulations was time-dependent. Zn/Al layered 
double hydroxide did not show that inhibition. Following 
incubation of ACE with 0.5 µg/mL of PZAE, approximately 
43% and 68% decreases in ACE activity were observed at 
30 and 60 minutes of incubation, respectively, as compared 
with the untreated cells. Under these same conditions, 
incubation of ACE with PZAC (0.5 µg/mL) resulted in 
21% and 55% decreases in ACE activity at these same time 
points, respectively. Table 5 shows slightly decreases in ACE 
activity with 0.5 µg/mL of PZAE and PZAC for 90 minutes 
as compared with that for 60 minutes.
Conclusion
This work shows that intercalation of perindopril, an 
antihypertensive drug, into Zn/Al-LDH can be accomplished 
using two methods, namely ion-exchange and coprecipitation. 
The basal spacing of the nanocomposites was expanded 
to 21.7 Å and 19.9 Å when using ion-exchange and 
coprecipitation, respectively. The results suggest that 
the perindopril molecules were arranged as a monolayer 
within the interlayers when using the coprecipitation 
method and as a bilayer when using the ion-exchange 
method. As a result of the intercalation process, the 
thermal stability and sustained release of the intercalated 
perindopril were considerably enhanced compared with 
its free counterpart. The duration of release of perindopril 
from the nanocomposite prepared by the coprecipitation 
method was much longer than that of perindopril prepared 
by the ion-exchange method at pH 7.4. It is possible that 
the intercalated guest molecules, arranged in a monolayer 
fashion within the interlayers, have a weaker repulsive force 
and stronger affinity towards the LDH interlayers. The 
release of perindopril from the nanocomposite was found 
to be governed by pseudo-second order kinetics. An in vitro 
antihypertensive assay showed that the intercalation process 
has similar effectiveness on the antihypertensive properties of   
perindopril.
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